Analysen von David Adlington
| 24.04.14 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 24.04.14 | Fresenius overweight | JP Morgan Chase & Co. | |
| 24.04.14 | Fresenius Medical Care (FMC) St. Neutral | JP Morgan Chase & Co. | |
| 24.04.14 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
| 11.04.14 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 09.04.14 | Gerresheimer overweight | JP Morgan Chase & Co. | |
| 04.04.14 | Fresenius Medical Care (FMC) St. Neutral | JP Morgan Chase & Co. | |
| 18.12.12 | Fresenius neutral | J.P. Morgan Cazenove | |
|
Werbung
|
|||
| 06.12.12 | Carl Zeiss Meditec overweight | J.P. Morgan Cazenove | |
| 22.11.12 | Gerresheimer overweight | J.P. Morgan Cazenove | |
| 14.11.12 | Sonova overweight | J.P. Morgan Cazenove | |
| 15.10.12 | Gerresheimer overweight | J.P. Morgan Cazenove | |
| 15.10.12 | Carl Zeiss Meditec overweight | J.P. Morgan Cazenove | |
| 12.10.12 | RHÖN-KLINIKUM neutral | J.P. Morgan Cazenove | |
| 12.10.12 | STADA neutral | J.P. Morgan Cazenove | |
| 12.10.12 | Fresenius neutral | J.P. Morgan Cazenove | |
| 08.10.12 | Gerresheimer overweight | J.P. Morgan Cazenove | |
| 02.10.12 | Gerresheimer overweight | J.P. Morgan Cazenove | |
| 04.09.12 | Fresenius overweight | J.P. Morgan Cazenove | |
| 04.09.12 | RHÖN-KLINIKUM neutral | J.P. Morgan Cazenove | |